NextCell Pharma AB (STO:NXTCL)
Sweden · Delayed Price · Currency is SEK 1.300
-0.002 (-0.15%)
At close: Mar 4, 2026
NextCell Pharma AB Employees
NextCell Pharma AB had 24 employees as of August 31, 2024. The number of employees increased by 7 or 41.18% compared to the previous year.
Employees
24
Change (1Y)
7
Growth (1Y)
41.18%
Revenue / Employee
461.02K SEK
Profits / Employee
-1.46M SEK
Market Cap
144.81M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Aug 31, 2024 | 24 | 7 | 41.18% |
| Aug 31, 2023 | 17 | 2 | 13.33% |
| Aug 31, 2022 | 15 | 2 | 15.38% |
| Aug 31, 2021 | 13 | 3 | 30.00% |
| Aug 31, 2020 | 10 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Magle Chemoswed Holding AB | 144 |
| IRLAB Therapeutics AB | 31 |
| Sprint Bioscience AB | 30 |
| Xbrane Biopharma AB | 26 |
| Biovica International AB | 24 |
| Intervacc AB | 15 |
| Simris Group AB (PUBL) | 6 |
| Isofol Medical AB | 6 |